Disease activity patterns in a monocentric cohort of SLE patients a seven-year follow-up study
Zen Margherita, MDBassi Nicola, PhDNalotto Linda, MD
Canova Mariagrazia, MDBettio Silvano, MDGatto Mariele, MDGhirardello Anna, PhDIaccarino Luca, PhDPunzi Leonardo, MDDoria Andrea, MD
Please address correspondence to: Prof. Andrea Doria,
Division of Rheumatology, Department of Medicine, University of Padova, Via Giustiniani 2, 35128 Padova, Italy. E-mail: adoria@unipd.it
Received on December 20, 2011; accepted in revised form on January 12, 2012.© Copyright EXPERIMENTALCLINICAL RHEUMATOLOGY AND
2012.
Competing interests: none declared.
Introduction
Systemic lupus erythematosus (SLE) is an autoimmune rheumatic disease char-acterised festations and organ involvement (1, 2). by a variety of clinical mani-Disease time and are can occur even in patients activity often uctuates over with a previously inactive disease, which makes these ares often unpredictable. Recent (RCTs) randomised of SLE course and highlighted the dif-con rmed the controlled heterogeneity trials culties outcomes (3-5).
in de ning clinically relevant Some order to identify disease activity in SLE indices have been developed in patients; als are Systemic Lupus Erythematosus the most used in clinical tri-Disease Activity the Index the SLEDAI (8), and British Isles Assessment Group Modi ed 2000 (SLEDAI) (6), SLEDAI (SLEDAI-2K) (M-SLEDAI) (7), index (BILAG) (9) and currently there is no consensus on which of them is the most suitable index to describe SLE ac-tivity (10).
However, disease looking at the variation major patterns of disease activity have activity score over time, three of been (8, identi ed in persistent 11-13): relapsing-remitting, disease chronic activity active, previous de ned studies as periods of disease activity interspersed characterised over time; by with periods of disease inactivity; long quiescent, de ned as absence of disease activity. patterns used in these studies (8, 11-13) However, the de nitions of are different, which makes the compar-ison in of the results dif cult. disease activity were considered in the these studies patients with Moreover, minimal same group of those with chronic dis-ease approach to these patients is different. activity although the therapeutic The evaluation of SLE course is crucial in who could bene t from the introduction estimating the number of patients of the new targeted therapies.
The disease aim of our study was to examine currence activity SLE patients monitored during a 7-year in a monocentric patterns and cohort are oc-of follow-up.
Patients and methods
We used our Lupus Database which
857
included 1970 and 2010. Patients attending our patients recruited between outpatient after 1990 and before 2004 and seen at clinic, diagnosed with SLE least every four months between Janu-ary 2004 and December 2010 were in-cluded in the study.
All patients met at least four of the re-vised tology American College of (14). were Clinical Classi cation and criteria Rheuma-for SLE ing to standardised protocol recorded at laboratory each visit ndings stored in a dedicated database.and accord-were De nitions of disease activity patternsDisease
the SLEDAI-2K index which was cal-activity was monitored using culated patterns were evaluated at each year of at each visit. Disease activity observation in order to obtain their an-nual incidence.
Annual disease activity patterns were de ned using SLEDAI-2K, excluding serology, cent disease (CQD), a SLEDAI-2K=0 as follows: clinical quies-in the three annual visits; minimal dis-ease activity (MDA), a SLEDAI-2K=1 in one or more annual visits; chronic active 2K≥2 in at least two out of the three disease (CAD), a SLEDAI-annual visits; relapsing-remitting dis-ease out of 3 annual visits. We excluded se-(RRD), a SLEDAI-2K≥2 in one rology in order to focus our study on clinical activity.
The characterised by absence of activity for CQD pattern describes disease at least 1 year. This minimal time inter-val was selected to be consistent with criteria for remission (10, 15).
The which continues to be active for at least CAD pattern re ects a disease 8 months per year. The interval of eight months considered was chosen because it was ful. The to be clinically meaning-tuating disease activity over one year, RRD pattern describe a uc-with with periods of silent disease. We have periods of activity interspersed introduced the pattern of MDA charac-terised activity by periods of minimal disease The with therapeutic which are approach variable to in length. patients with CAD or RRD.
MDA differs from that patients used in
热门文档